- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06731686
Single-center Retrospective Study : Developmental Trajectories of Children Born Prematurely Before 32 Weeks Assessed With the Revised Brunet Lézine Scale at 1, 2 and 3 Years
December 9, 2024 updated by: Centre Hospitalier Intercommunal Creteil
This study will assess professionals in the CHI Créteil neonatal department and the Val de Marne perinatal network to gain a better understanding of the developmental trajectories of children hospitalized at the CHI Créteil, with a view to optimizing their care in the long term
Study Overview
Study Type
Observational
Enrollment (Actual)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Créteil, France, 94000
- Chi Creteil
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Children born prematurely before 32 weeks
Description
Inclusion Criteria:
- Children born at CHI Créteil between 2012 and 2022, included in the Val de Marne perinatal network.
- Children seen in pediatrician-psychomotor consultation with assessment by the BLR scale at 1 year AC.
Exclusion Criteria:
- Children born with a term of birth ≥ 32 weeks + 1 day.
- Child removed from the Val de Marne perinatal network monitoring from the age of 1 year AC: Death or parental decision.
- Children presenting with cerebral palsy, blindness or deafness at the age of 1 year AC.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Overall DQ obtained on the BLR scale at 1, 2 and 3 years, collected by the psychomotor therapists at CHI Créteil.
Time Frame: 1, 2 and 3 years
|
1, 2 and 3 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Analysis of the 4 sub-scores (movement and posture, language, socialization, coordination) obtained on the BLR scale at 1, 2 and 3 years, collected by the psychomotor therapists at CHI Créteil.
Time Frame: 1,2 and 3 years
|
1,2 and 3 years
|
|
Analysis of family socio-demographic data : level of education
Time Frame: 1,2 and 3 years
|
1,2 and 3 years
|
|
Analysis of family socio-demographic data : age of parents
Time Frame: 1,2 and 3 years
|
1,2 and 3 years
|
|
Analysis of birth data : term
Time Frame: 1, 2 and 3 years
|
1, 2 and 3 years
|
|
Analysis of birth data : weight
Time Frame: 1,2 and 3 years
|
1,2 and 3 years
|
|
Analysis of duration of hospitalization
Time Frame: 1,2 and 3 years
|
1,2 and 3 years
|
|
Evaluate the concordance of BLR scale at 5 years with the measurement scores (not validated) used by the Val de Marne perinatal network (and all the Ile de France perinatal networks) filed out during the same consultations
Time Frame: 5 years
|
5 years
|
|
Evaluate the concordance of BLR scale at 5 years with the measurement scores (not validated) used by the Val de Marne perinatal network (and all the Ile de France perinatal networks) filed out during the same consultations
Time Frame: 1,2 and 3 years
|
1,2 and 3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 23, 2023
Primary Completion (Actual)
June 17, 2024
Study Completion (Actual)
June 17, 2024
Study Registration Dates
First Submitted
March 25, 2024
First Submitted That Met QC Criteria
December 9, 2024
First Posted (Estimated)
December 12, 2024
Study Record Updates
Last Update Posted (Estimated)
December 12, 2024
Last Update Submitted That Met QC Criteria
December 9, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PREMADEV
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Birth
-
University of VirginiaCompletedPremature Birth of NewbornUnited States
-
Shaare Zedek Medical CenterTerminatedPremature Birth of NewbornIsrael
-
Case Western Reserve UniversityCompleted
-
Indiana UniversityCompletedPremature LaborUnited States
-
Washington University School of MedicineUniversity of Southern CaliforniaCompletedPremature Birth of NewbornUnited States
-
University of ArkansasCompletedPremature Birth of NewbornUnited States
-
University of California, San FranciscoUniversity of California, San Diego; University of California, Los Angeles; Kaiser...CompletedPremature Birth of NewbornUnited States
-
Universidad Complutense de MadridCompletedPremature Birth of Newborn
-
Elgan Pharma Ltd.Terminated
-
Hôpital de la Croix-RousseUnknownPremature Birth of NewbornFrance
Clinical Trials on Retrospective study
-
University of Texas Southwestern Medical CenterCompletedDiabetic Foot UlcerUnited States
-
IRCCS San Camillo, Venezia, ItalyUniversita di Verona; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico and other collaboratorsEnrolling by invitationCalpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2AItaly
-
University Hospital, Strasbourg, FranceUnknown
-
Meir Medical CenterUnknownPrimary Sjogren Syndrome With Multisystem Involvement
-
Kocaeli UniversityCompleted
-
University Hospital, Strasbourg, FranceUnknown
-
Hospices Civils de LyonUnknownCentral Nervous System LymphomaFrance
-
National Taiwan University HospitalCompletedHospitalization Rate | Mortality Rate | Functional Recovery | Left Ventricle Ejection Fraction | NT-pro BNPTaiwan
-
Lahey ClinicGenentech, Inc.Completed